Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 302

1.

Albumin binding and anticancer effect of magnesium oxide nanoparticles.

Behzadi E, Sarsharzadeh R, Nouri M, Attar F, Akhtari K, Shahpasand K, Falahati M.

Int J Nanomedicine. 2018 Dec 27;14:257-270. doi: 10.2147/IJN.S186428. eCollection 2019.

2.

Curcumin as a therapeutic agent in leukemia.

Kouhpeikar H, Butler AE, Bamian F, Barreto GE, Majeed M, Sahebkar A.

J Cell Physiol. 2019 Jan 4. doi: 10.1002/jcp.28072. [Epub ahead of print] Review.

PMID:
30609023
3.

FLT3-specific curcumin micelles enhance activity of curcumin on FLT3-ITD overexpressing MV4-11 leukemic cells.

Tima S, Okonogi S, Ampasavate C, Berkland C, Anuchapreeda S.

Drug Dev Ind Pharm. 2018 Dec 20:1-26. doi: 10.1080/03639045.2018.1562462. [Epub ahead of print]

PMID:
30572745
4.
5.

Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.

Li H, Krstin S, Wink M.

Phytomedicine. 2018 Nov 15;50:213-222. doi: 10.1016/j.phymed.2018.09.169. Epub 2018 Sep 17.

PMID:
30466981
6.

Co-activation of WT1 and AP-1 proteins on WT1 gene promoter to induce WT1 gene expression in K562 cells.

Anuchapreeda S, Rungrojsakul M, Tima S, Chiampanichayakul S, Krig SR.

Cell Signal. 2019 Jan;53:339-347. doi: 10.1016/j.cellsig.2018.11.001. Epub 2018 Nov 3.

PMID:
30395942
7.

Spice-derived phenolic, malabaricone B induces mitochondrial damage in lung cancer cells via a p53-independent pathway.

Tyagi M, Maity B, Saha B, Bauri AK, Subramanian M, Chattopadhyay S, Patro BS.

Food Funct. 2018 Nov 14;9(11):5715-5727. doi: 10.1039/c8fo00624e.

PMID:
30318526
8.

Evaluation of curcumin, a natural product in turmeric, on Burkitt lymphoma and acute myeloid leukemia cancer stem cell markers.

Li Y, Domina A, Lim G, Chang T, Zhang T.

Future Oncol. 2018 Oct;14(23):2353-2360. doi: 10.2217/fon-2018-0202. Epub 2018 Aug 24.

PMID:
30139269
9.

Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies.

Murray-Stewart T, Dunworth M, Lui Y, Giardiello FM, Woster PM, Casero RA Jr.

PLoS One. 2018 Aug 23;13(8):e0202677. doi: 10.1371/journal.pone.0202677. eCollection 2018.

10.

Femtosecond laser pulse assisted photoporation for drug delivery in Chronic myelogenous leukemia cells.

Banavath HN, Allam SR, Valathati SS, Sharan A, Rajasekaran B.

J Photochem Photobiol B. 2018 Oct;187:35-40. doi: 10.1016/j.jphotobiol.2018.07.031. Epub 2018 Jul 31.

PMID:
30098520
11.

SWATH-MS based quantitative proteomics analysis reveals that curcumin alters the metabolic enzyme profile of CML cells by affecting the activity of miR-22/IPO7/HIF-1α axis.

Monteleone F, Taverna S, Alessandro R, Fontana S.

J Exp Clin Cancer Res. 2018 Jul 25;37(1):170. doi: 10.1186/s13046-018-0843-y.

12.

Validated UPLC-MS/MS method for the quantification of dasatinib in plasma: Application to pharmacokinetic interaction studies with nutraceuticals in Wistar rats.

Maher HM, Alzoman NZ, Shehata SM, Abanmy NO.

PLoS One. 2018 Jun 14;13(6):e0199208. doi: 10.1371/journal.pone.0199208. eCollection 2018.

13.

An LC-MS/MS method for simultaneous determination of curcumin, curcumin glucuronide and curcumin sulfate in a phase II clinical trial.

Kunati SR, Yang S, William BM, Xu Y.

J Pharm Biomed Anal. 2018 Jul 15;156:189-198. doi: 10.1016/j.jpba.2018.04.034. Epub 2018 Apr 23.

PMID:
29727780
14.

Repositioning of difluorinated propanediones as inhibitors of histone methyltransferases and their biological evaluation in human leukemic cell lines.

Pal T, Sharda A, Khade B, Ramaa CS, Gupta S.

Anticancer Agents Med Chem. 2018 Apr 4. doi: 10.2174/1871520618666180404125721. [Epub ahead of print]

PMID:
29623853
15.

Curcumin differentially affects cell cycle and cell death in acute and chronic myeloid leukemia cells.

Martínez-Castillo M, Villegas-Sepúlveda N, Meraz-Rios MA, Hernández-Zavala A, Berumen J, Coleman MA, Orozco L, Cordova EJ.

Oncol Lett. 2018 May;15(5):6777-6783. doi: 10.3892/ol.2018.8112. Epub 2018 Feb 23.

16.
17.

Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells.

Garitano-Trojaola A, José-Enériz ES, Ezponda T, Unfried JP, Carrasco-León A, Razquin N, Barriocanal M, Vilas-Zornoza A, Sangro B, Segura V, Prósper F, Fortes P, Agirre X.

Oncotarget. 2018 Feb 5;9(16):12842-12852. doi: 10.18632/oncotarget.24401. eCollection 2018 Feb 27.

18.

Microfluidic Assisted Nanoprecipitation of PLGA Nanoparticles for Curcumin Delivery to Leukemia Jurkat Cells.

Leung MHM, Shen AQ.

Langmuir. 2018 Apr 3;34(13):3961-3970. doi: 10.1021/acs.langmuir.7b04335. Epub 2018 Mar 22.

PMID:
29544247
19.

Curcumin induces apoptosis and inhibits proliferation in infantile hemangioma endothelial cells via downregulation of MCL-1 and HIF-1α.

Lou S, Wang Y, Yu Z, Guan K, Kan Q.

Medicine (Baltimore). 2018 Feb;97(7):e9562. doi: 10.1097/MD.0000000000009562.

20.

Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth.

Larasati YA, Yoneda-Kato N, Nakamae I, Yokoyama T, Meiyanto E, Kato JY.

Sci Rep. 2018 Feb 1;8(1):2039. doi: 10.1038/s41598-018-20179-6.

Supplemental Content

Loading ...
Support Center